Archrock, Inc. (AROC) — Institutional Holders & Catalysts | BiotechEdge

Catalysts Convergence Squeeze Signals Cash Runway Insiders Research

Home›Companies›Archrock, Inc. (AROC)

Archrock, Inc.

AROC

Held by 1 specialist biotech fund

1 fund opened new positions. Short interest: 6.7% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

1.7/10

1 fund opened new positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

Recent insider sells only●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Driehaus Capital

Position history (shares)

Driehaus Capital

2 quarters

Position Trend

May 15, 2025

$25.4M

1 fund

Aug 14, 2025

$19.9M

1 fund

Nov 14, 2025

0 funds

Feb 17, 2026

0 funds

-100% total institutional value over 4 quarters

Short Interest

Short Shares

8.38M

Change

+3.5%

Days to Cover

5.0

% of Float

6.7%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Recent Insider Activity

Aron Doug SSR VICE PRESIDENT, CFO

SaleMar 31, 2026

Aron Doug SSR VICE PRESIDENT, CFO

SaleMar 31, 2026

Start free trial for dollar amounts, share counts, and AI context.

Position Details

Driehaus CapitalEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

3 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

Aron Doug SSR VICE PRESIDENT, CFOSaleMar 31, 2026SEC Filing →

Shares: 71,500Value: $2,546,115Price: $35.61

AROC | CFO Sells $2.5M Position

Doug Aron (CFO) liquidated 71,500 shares at $35.61, representing a material sale but lacking insider conviction signal—CFOs routinely diversify or fund personal obligations through programmatic selling. Without context on portfolio size, vesting schedules, or 10b5-1 plan parameters, the sale alone carries limited negative weight.

Aron Doug SSR VICE PRESIDENT, CFOSaleMar 31, 2026SEC Filing →

Shares: 98,050Value: $3,408,218Price: $34.76

AROC | CFO Doug Aron Sells $3.4M Position

CFO sold ~98K shares at $34.76, likely a routine diversification/liquidity event given the modest percentage of total compensation and no obvious technical breakdown. Without knowing his remaining holdings or vesting schedules, this carries minimal signal—watch for patterns across other insiders or material news that might explain opportunistic timing.